Delivery Order SPE2DB22D3004-SPE2DB25FNG94

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNG94
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the procurement of Emgality 300 mg (100 mg x 3 syringes) medication, with a ceiling value of $2,242.98 and a completion date of October 24, 2024. This contract is not designated as a set-aside and is a firm fixed-price delivery order, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is a task order under the larger DLA IDC, demonstrating AmerisourceBergen's role as a key supplier of essential medical commodities to the U.S. Department of Defense and its related healthcare programs.

Generated 1/22/25, 9:12 AM